Influence of immunotherapy with pegylated interferon-alpha on platelet monoamine oxidase activity in high-risk melanoma patients

被引：0
|
作者：
Fekkes, D [1 ]
van Gool, AR [1 ]
van Ojik, HH [1 ]
Bannink, M [1 ]
Mulder, PGH [1 ]
Kruit, WHJ [1 ]
Eggermont, AMM [1 ]
Stoter, G [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80165-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [31] Adjuvant high-dose interferon-α in high-risk melanoma patients:: requiem for an approval?
    Saiag, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1999, 126 (03): : 211 - 213
  • [32] Adjuvant therapy of high-risk melanoma: The role of high-dose interferon alpha-2b
    Kirkwood, JM
    Strawderman, MH
    Ernstoff, MS
    Smith, T
    Borden, E
    Blum, R
    ADJUVANT THERAPY OF CANCER VIII, 1997, 8 : 251 - 257
  • [33] ADJUVANT THERAPY OF HIGH-RISK MALIGNANT-MELANOMA PATIENTS WITH GAMMA-INTERFERON
    LANDTHALER, M
    BRAUNFALCO, O
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (04) : 687 - 688
  • [34] Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-α in high-risk melanoma patients
    Van Gool, AR
    Van Ojik, HH
    Kruit, WHJ
    Mulder, PGH
    Fekkes, D
    Bannink, M
    Scharpé, S
    Stoter, G
    Eggermont, AMM
    Maes, M
    Verkerk, R
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2004, 24 (07): : 411 - 415
  • [35] Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience
    Tas, Faruk
    Kurul, Sidika
    Camlica, Hakan
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2006, 23 (04) : 471 - 477
  • [36] Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease
    Lens, Marko
    DERMATOLOGIC THERAPY, 2006, 19 (01) : 9 - 18
  • [37] DESPITE PERSISTENT HIGH PLASMA LEVELS PEGYLATED INTERFERON-ALPHA ONLY TRANSIENTLY INDUCES INTERFERON STIMULATED GENES IN THE LIVER OF PATIENTS WITH CHRONIC HEPATITIS C
    Dill, M. T.
    Makowska, Z.
    Vogt, J. E.
    Filipowicz, M.
    Terracciano, L.
    Roth, V.
    Heim, M. H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S55 - S55
  • [38] Interferon-alpha treatment may negatively influence disease progression in melanoma patients by hyperactivation of STAT3 protein
    Humpolikova-Adamkova, L.
    Kovarik, J.
    Dusek, L.
    Lauerova, L.
    Boudny, V.
    Fait, V.
    Fojtova, M.
    Krejci, E.
    Kovarik, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (07) : 1315 - 1323
  • [39] Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: Results of a randomized trial
    Hersey, P
    Coates, AS
    McCarthy, WH
    Thompson, JF
    Sillar, RW
    McLeod, R
    Gill, PG
    Coventry, BJ
    McMullen, A
    Dillon, H
    Simes, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) : 4181 - 4190
  • [40] Despite persistent high plasma levels pegylated Interferon-alpha only transiently induces interferon stimulated genes in the liver of patients with chronic hepatitis C
    Dill, Michael T.
    Makowska, Zuzanna
    Vogt, Julia E.
    Filipowicz, Magdalena
    Terracciano, Luigi
    Roth, Volker
    Heim, Markus H.
    SWISS MEDICAL WEEKLY, 2012, 142 : 2S - 2S
12345